B. Riley Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.13M Buy
8,579
+1,948
+29% +$197K 0.12% 164
2022
Q1
$736K Sell
6,631
-5,795
-47% -$612K 0.06% 256
2021
Q4
$1.28M Buy
12,426
+2,409
+24% +$279K 0.09% 200
2021
Q3
$1.26M Buy
10,017
+4,472
+81% +$579K 0.1% 198
2021
Q2
$688K Buy
5,545
+319
+6% +$40.1K 0.08% 194
2021
Q1
$617K Buy
5,226
+332
+7% +$38.9K 0.07% 205
2020
Q4
$573K Sell
4,894
-208
-4% -$22.9K 0.07% 190
2020
Q3
$530K Buy
5,102
+2,054
+67% +$206K 0.06% 219
2020
Q2
$280K Sell
3,048
-880
-22% -$84.4K 0.03% 315
2020
Q1
$354K Buy
+3,928
New +$418K 0.04% 327
2015
Q3
Sell
-1,162
Closed -$86K 509
2015
Q2
$86K Hold
1,162
0.07% 301
2015
Q1
$90K Buy
1,162
+95
+9% +$7.2K 0.07% 301
2014
Q4
$77K Hold
1,067
0.06% 317
2014
Q3
$66K Hold
1,067
0.05% 360
2014
Q2
$68K Sell
1,067
-4,150
-80% -$252K 0.04% 412
2014
Q1
$321K Buy
+5,217
New +$304K 0.24% 112

Other funds holding MDT

B. Riley Wealth Management's MDT Position: Q2 2022 in Review

B. Riley Wealth Management increased its Medtronic (MDT) stake by 29% in Q2 2022, buying an estimated $197K and bringing the position to 8,579 shares worth $1.13M. The position accounts for 0.12% of the portfolio, ranked #164.

B. Riley Wealth Management first reported a position in MDT in Q1 2014 and has held it in 16 quarters since. The position peaked at $1.28M in Q4 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • B. Riley Wealth Management held 8,579 shares of Medtronic worth $1.13M as of Q2 2022.
  • B. Riley Wealth Management bought 1,948 Medtronic shares in Q2 2022, an estimated $197K.
  • Medtronic made up 0.12% of B. Riley Wealth Management's portfolio in Q2 2022, its #164 holding.
  • B. Riley Wealth Management first reported a position in Medtronic in Q1 2014 and has held it in 16 quarters since.
  • B. Riley Wealth Management's Medtronic position peaked at $1.28M in Q4 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.